Humacyte
Price & Volume
Stats
See moreOpen | $1.74 |
Previous Close | $1.70 |
Day Range | $1.68-$1.81 |
52W Range | $1.15-$6.77 |
Market Cap | $281.1M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $818,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$80.5M |
Diluted EPS | -$0.47 |
News
See moreYahoo Finance • 7 days ago
Humacyte Plans To File IND For Coronary Tissue Engineered Vessel In Q4
Yahoo Finance • 7 days ago
Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)
Yahoo Finance • 10 days ago
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
Yahoo Finance • 12 days ago
Humacyte files $350M mixed securities shelf
About
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
CFO | Mr. Dale A. Sander |
Address | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |
